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cystic changes, and epithelial proliferation and impaired
epithelia–matrix interaction result in a loss of BBM and
cellular interdigitation paralleled by the loss of NaPi-2.
Advanced renal damage was associated with phosphaturia,
suggesting functional insufﬁciency of tubular NaPi-2
reabsorption.
Therefore, there is a possibility that the loss of the NaPi-2
system in the proximal tubule BBM, as well as the elevated
FGF23 suppressing renal tubular phosphate reabsorption
and 1a-hydroxylase activity, might be involved in the
pathogenesis of increased renal phosphate excretion and
hypophosphatemia in patients with ADPKD. However,
further studies are necessary to elucidate what is exactly
responsible for the increased FGF23 secretion in ADPKD
and the correlation between the increased FGF23 and the
loss of NaPi-2. Whether the increase in serum FGF23 in
patients with ADPKD precedes or follows the decrease
in glomerular ﬁltration rate should also be further studied
in the future.
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The Authors Reply: We appreciate the interest of Dr Park1
and his group in our research2 and acknowledge the fact that
alternative explanations might be provided for the renal leak
of phosphate (P) observed in autosomal dominant polycystic
kidney disease (ADPKD). The mechanism suggested by Vogel
et al.3 offers a valid explanation for a renal leak of P in
polycystic kidney disease in rodents: a loss of expression of
the NaPi-2 cotransporter due to cyst development could
indeed account for a renal P wasting and hypophosphatemia
in such an animal model. However, this putative mechanism
implies that cyst development is the primary trigger for the
renal P loss: secondary decrease, and not increase in FGF23
levels, would thus be expected to occur. This is the reason
why we consider that cyst development alone cannot account
for the renal leak of P observed in our study. Furthermore,
Vogel et al. studied Han:SPRD rats that were in the late stage
of polycystic disease with advanced renal insufficiency,
whereas in our ADPKD patient average estimated glomerular
filtration rate was 94ml/min per 1.73m2. To our knowledge,
no data have been reported examining the localization of
NaPi-IIa or other phosphate transporters in the kidney from
ADPKD patients. This appears to be relevant as the relative
contribution of NaPi-IIa to renal phosphate handling in
humans is controversial.4 Therefore, several mechanisms may
account for the renal leak of phosphate observed in patients
with ADPKD, and further research is needed to unveil the
most important one.
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